PSDV
pSivida Corp.
NasdaqGM
People also watch:ALIMPRANOPXAONTYBIOD
3.790.00 (0.00%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close3.79
Open3.80
Bid3.78 x 400
Ask3.79 x 100
52wk Range2.37 - 5.81
Day's Range3.75 - 3.80
Volume32,921
Avg Vol (3m)74,914
As of 2:26 PM EDT. NasdaqGM Real Time Price. Market open.
  • Capital Cube22 hours ago

    pSivida Corp.: Strong price momentum but will it sustain?

    pSivida Corp. relative valuation is OVERVALUED and it has a fundamental analysis score of 43. Our analysis is based on comparing pSivida Corp. with the following peers – Nektar Therapeutics, Regeneron Pharmaceuticals, Inc., Alimera Sciences, Inc., XOMA Corporation, Abbott Laboratories, Merck & Co., Inc., Heron Therapeutics Inc, Pfizer Inc., Valeant Pharmaceuticals International, Inc. and Emisphere […]

  • Capital Cube8 days ago

    ETF’s with exposure to pSivida Corp. : July 20, 2016

    Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to pSivida Corp.Here are 5 ETF’s with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns […] (Read more...) The post ETF’s with exposure to pSivida Corp. : July 20, 2016 appeared first on CapitalCube.